Publications

Title: Synergistic action of propolis with levodopa in the management of Parkinsonism inDrosophila melanogaster
Author(s): Emmanuel Tiyo Ayikobua, Josephine Kasolo, Keneth Iceland Kasozi, Ejike Daniel Eze, Abass Safiriyu, Herbert Izo Ninsiima, Kennedy Kiyimba, Jackline Namulema, Edward Jjesero, Fred Ssempijja, Ibrahim Semuyaba, Daniel Chans Mwandah, Kyobe Ronald Kimanje, Muhamudu Kalange, Alfred Omachonu Okpanachi3, Mir
Year 2020
Publisher: Journal of Complementary and Integrative Medicine, alter de Gruyter GmbH, Berlin/Boston
URI: https://publications.kiu.ac.ug/publication-page.php?i=synergistic-action-of-propolis-with-levodopa-in-the-management-of-parkinsonism-indrosophila-melanogaster
File: PDF
Keywords: aging antioxidant activity catalase climbing index Drosophila melanogaster Levodopa induced dyskinesia lifespan oxidative stress Parkinson’s disease Parkinsonism PINK1B9 propolis

Background: The Phosphatase and tensin-induced putative kinase 1 (PINK1B9) mutant for Drosophila melanogaster is a key tool that has been used in assessing the pathology of Parkinsonism and its possible remedy. This research was targeted toward determining the effects of ethanolic extract of propolis, with levodopa therapy in the management of Parkinsonism. Method: The PINK1B9 flies were divided into groups and fed with the different treatment doses of ethanoic extract of propolis. The treatment groups were subjected to 21 days of administration of propolis and the levodopa at different doses after which percentage climbing index, antioxidant activity and lifespan studies were done.

Results: Propolis alone improved motor activity, antioxidant and lifespan in Drosophila melanogaster than in PINK1 flies. Propolis in combination with levodopa significantly (P<0.05) improved physiological parameters at higher than lower concentrations in Parkinsonism Drosophila melanogaster demonstrating its importance in managing side effects associated with levodopa. Conclusion: Propolis is a novel candidate as an alternative and integrative medicinal option to use in the management of Parkinsonism in both animals and humans at higher concentrations.


KIU

Our Contacts

Kampala International University,
Box 20000, Ggaba Road, Kansanga, Kampala

+(256) 392 001 816
+(256) 752 800 802